Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease
- 2 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 118 (1), 295-304
- https://doi.org/10.1093/cvr/cvaa344
Abstract
Aims: Patients with atrial fibrillation (AF) and rheumatic heart disease (RHD), especially mitral stenosis, are assumed to be at high risk of stroke, irrespective of other factors. We aimed to re-evaluate stroke risk factors in a contemporary cohort of AF patients. Methods and results: We analysed data of 15 400 AF patients presenting to an emergency department and who were enrolled in the global RE-LY AF registry, representing 47 countries from all inhabited continents. Follow-up occurred at 1 year after enrolment. A total of 1788 (11.6%) patients had RHD. These patients were younger (51.4±15.7 vs. 67.8±13.6 years), more likely to be female (66.2% vs. 44.7%) and had a lower mean CHA2DS2-VASc score (2.1±1.7 vs. 3.7±2.2) as compared to patients without RHD (all P<0.001). Significant mitral stenosis (average mean transmitral gradient 11.5±6.5 mmHg) was the predominant valve lesion in those with RHD (59.6%). Patients with RHD had a higher baseline rate of anticoagulation use (60.4% vs. 45.2%, P<0.001). Unadjusted stroke rates at 1 year were 2.8% and 4.1% for patients with and without RHD, respectively. The performance of the CHA2DS2-VASc score was modest in both groups [stroke at 1 year, c-statistics 0.69, 95% confidence interval (CI) 0.60–0.78 and 0.63, 95% CI 0.61–0.66, respectively]. In the overall cohort, advanced age, female sex, prior stroke, tobacco use, and non-use of anticoagulation were predictors for stroke (all P<0.05). Mitral stenosis was not associated with stroke risk (adjusted odds ratio 1.07, 95% CI 0.67–1.72, P=0.764). Conclusion: The performance of the CHA2DS2-VASc score was modest in AF patients both with and without RHD. In this cohort, moderate-to-severe mitral stenosis was not an independent risk factor for stroke.Funding Information
- German Heart Foundation
This publication has 31 references indexed in Scilit:
- A New Risk Scheme to Predict Ischemic Stroke and Other Thromboembolism in Atrial Fibrillation: The ATRIA Study Stroke Risk ScoreJournal of the American Heart Association, 2013
- CHADS 2 , CHA 2 DS 2 -VASc, and long-term stroke outcome in patients without atrial fibrillationNeurology, 2013
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort studyEuropean Heart Journal, 2012
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based ApproachSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2010
- Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto StudyEuropean Heart Journal, 2009
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001
- Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillationThe Annals of Thoracic Surgery, 1996
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991
- Atrial Fibrillation: A Major Contributor to Stroke in the ElderlyArchives of Internal Medicine, 1987
- Epidemiologic assessment of chronic atrial fibrillation and risk of strokeNeurology, 1978